PA1-21614

antibody from Invitrogen Antibodies

Targeting: ACKR2 CCBP2, CCR10, CCR9, CMKBR9, D6

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

PA1-21614

Provider

Invitrogen Antibodies

Product name

CCRD6 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Synthetic peptide

Description

Recommended positive controls: Human spleen.

Concentration

1 mg/mL

References

Submitted references

Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.

Yu KD, Wang X, Yang C, Zeng XH, Shao ZM
Oncotarget 2015 Sep 22;6(28):26519-27

---

Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.

Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, Shao ZM
Medical oncology (Northwood, London, England) 2014 Sep;31(9):145

---

Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.

Zeng XH, Ou ZL, Yu KD, Feng LY, Yin WJ, Li J, Shen ZZ, Shao ZM
Breast cancer research and treatment 2011 Feb;125(3):715-27

---

Chemokine decoy receptor d6 plays a negative role in human breast cancer.

Wu FY, Ou ZL, Feng LY, Luo JM, Wang LP, Shen ZZ, Shao ZM
Molecular cancer research : MCR 2008 Aug;6(8):1276-88

Immunohistochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical (Paraffin) analysis of human spleen tissue using (Product # PA1-21614) CCRD6 Polyclonal Antibody.